COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,032 Articles (22,627 medRxiv, 8,405 bioRxiv)

Most recent first Previous |  Page 1041: Articles 10401-10410  | Next

Neurodevelopmental outcomes at one year in offspring of mothers who test positive for SARS-CoV-2 during pregnancy
Edlow, A. G., Castro, V. M., Shook, L., Kaimal, A. J., Perlis, R. H.
10.1101/2021.12.15.21267849 — Posted: 2021-12-16
S Gene Target Failure (SGTF) in Commercial Multiplex RT-PCR assay as indicator to detect SARS-CoV-2 VOC B.1.1.7 lineage in Tamil Nadu, India
N M, V., A, K., V, K., A, R. K., Subramanian, G., Rathinasamy, A. S., Ramakrishnan, U., Potdar, V. A., Sivadoss, R., P, S., T S, S.
10.1101/2021.12.14.21251883 — Posted: 2021-12-16 Discussion: Onsite
The impact of COVID-19 restrictions on older adults' loneliness: Evidence from high-frequency panel data
Stolz, E., Mayerl, H., Freidl, W.
10.1101/2021.12.15.21267860 — Posted: 2021-12-16
Projected epidemiological consequences of the Omicron SARS-CoV-2 variant in England, December 2021 to April 2022
Barnard, R. C., Davies, N. G., Pearson, C. A. B., Jit, M., Edmunds, W. J.
10.1101/2021.12.15.21267858 — Posted: 2021-12-16 Discussion: Onsite
Heterogenous Cellular and Humoral Immune Trajectories after SARS-CoV-2 Infection: Compensatory Responses in a Population-Based Cohort
Menges, D., Zens, K. D., Ballouz, T., Caduff, N., Llanas-Cornejo, D., Aschmann, H. E., Domenghino, A., Pellaton, C., Perreau, M., Fenwick, C., Pantaleo, G., Kahlert, C. R., Muenz, C., Puhan, M. A., Fehr, J. S.
10.1101/2021.12.15.21267776 — Posted: 2021-12-16
Potential severity, mitigation, and control of Omicron waves depending on pre-existing immunity and immune evasion
Bartha, F. A., Boldog, P., Denes, A., Tekeli, T., Vizi, Z., Röst, G.
10.1101/2021.12.15.21267884 — Posted: 2021-12-16
Assessment of twenty-two SARS-CoV-2 rapid antigen tests against SARS-CoV-2: A laboratory evaluation study
Deerain, J. M., Tran, T., Batty, M. B., Yoga, Y., Druce, J., Mackenzie, C., Taiaroa, G., Taouk, M., Chea, S., Zhang, B., Prestedge, J., Ninan, M., Carville, K., Fielding, J., Catton, M., Williamson, D. A.
10.1101/2021.12.15.21267691 — Posted: 2021-12-16
The effect of anti-SARS-CoV-2 monoclonal antibody, bamlanivimab, on endogenous immune response to COVID-19 vaccination
Benschop, R. J., Tuttle, J. L., Zhang, L., Poorbaugh, J., Kallewaard, N. L., Vaillancourt, P., Crisp, M. L., Trinh, T. N. V., Freitas, J. J., Beasley, S., Daniels, M., Haustrup, N., Higgs, R. E., Nirula, A., Cohen, M. S., Marovich, M.
10.1101/2021.12.15.21267605 — Posted: 2021-12-16
REACT-1 round 15 final report: Increased breakthrough SARS-CoV-2 infections among adults who had received two doses of vaccine, but booster doses and first doses in children are providing important protection
Chadeau-Hyam, M., Eales, O., Bodinier, B., Wang, H., Haw, D., Whitaker, M., Walters, C. E., Jonnerby, J., Atchinson, C., Diggle, P. J., Page, A. J., Ashby, D., Barclay, W., Taylor, G., Cooke, G., Ward, H., Darzi, A., Donnelly, C. A., Elliott, P.
10.1101/2021.12.14.21267806 — Posted: 2021-12-16
A Cloth Facemask Causes No Major Respiratory or Cardiovascular Perturbations during Moderate to Heavy Exercise
Guardieiro, N. M., Barreto, G., Marticorena, F. M., Oliveira, T. N., Oliveira, L. F. d., Pinto, A. L. d. S., Prado, D. M. L. d., Saunders, B., Gualano, B.
10.1101/2021.12.14.21267800 — Posted: 2021-12-16 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).